CPDA-1 - 0942-6330-02 - (Anticoagulant Citrate Phosphate Dextrose Adenine)

Alphabetical Index


Drug Information of CPDA-1

Product NDC: 0942-6330
Proprietary Name: CPDA-1
Non Proprietary Name: Anticoagulant Citrate Phosphate Dextrose Adenine
Active Ingredient(s): 17.3; 188; 2; 140; 1.66    mg/63mL; mg/63mL; g/63mL; mg/63mL; g/63mL & nbsp;   Anticoagulant Citrate Phosphate Dextrose Adenine
Administration Route(s): INTRAVENOUS
Dosage Form(s): SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of CPDA-1

Product NDC: 0942-6330
Labeler Name: Fenwal, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BN770420
Marketing Category: NDA
Start Marketing Date: 20100525

Package Information of CPDA-1

Package NDC: 0942-6330-02
Package Description: 63 mL in 1 BAG (0942-6330-02)

NDC Information of CPDA-1

NDC Code 0942-6330-02
Proprietary Name CPDA-1
Package Description 63 mL in 1 BAG (0942-6330-02)
Product NDC 0942-6330
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Anticoagulant Citrate Phosphate Dextrose Adenine
Dosage Form Name SOLUTION
Route Name INTRAVENOUS
Start Marketing Date 20100525
Marketing Category Name NDA
Labeler Name Fenwal, Inc.
Substance Name ADENINE; ANHYDROUS CITRIC ACID; DEXTROSE MONOHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; TRISODIUM CITRATE DIHYDRATE
Strength Number 17.3; 188; 2; 140; 1.66
Strength Unit mg/63mL; mg/63mL; g/63mL; mg/63mL; g/63mL
Pharmaceutical Classes Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA]

Complete Information of CPDA-1


General Information